RxLive provides an AI-powered medication management software, telepharmacy services, and a population health pharmacy analytics platform serving a national customer base of healthcare providers. Founded in 2018 and based in St. Petersburg, Florida, the company combines analytics and telepharmacy to support population health pharmacy needs. RxLive raised $5M in a Series A and has now raised $8M in total to date. The company intends to use the Series A proceeds to expand its engineering, analytics, and sales and marketing teams. It also plans to invest in continuous improvement of its AI and the functionality of its medication management platform. The funding is positioned to support product development and broader deployment to its national customer base.

Total raised

$5M

Funding rounds

1

Latest round

Series A

Latest activity

Jul 2022